

Other version: http://onlinelibrary.wiley.com/store/10.1111/j.1538-7836.2008.03241.x/asset/j.1538-7836.2008.03241.x.pdf?v=1&t=gzs402...
![]() |
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? |
|
Authors | ||
Published in | Journal of Thrombosis and Haemostasis. 2009, vol. 7, no. 2, p. 363-364 | |
Keywords | Bias (Epidemiology) — Biomedical Research/standards — Cardiovascular Diseases/drug therapy — Humans — Platelet Aggregation Inhibitors/*therapeutic use — Ticlopidine/analogs & derivatives/therapeutic use | |
Identifiers | PMID: 19036060 | |
Full text |
![]() ![]() Other version: http://onlinelibrary.wiley.com/store/10.1111/j.1538-7836.2008.03241.x/asset/j.1538-7836.2008.03241.x.pdf?v=1&t=gzs402... |
|
Structures | ||
Research groups | Anticorps antiphospholipides (12) Geneva Platelet Group (13) | |
Citation (ISO format) | FONTANA, Pierre, DE MOERLOOSE, Philippe, RENY, Jean-Luc. Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?. In: Journal of Thrombosis and Haemostasis, 2009, vol. 7, n° 2, p. 363-364. doi: 10.1111/j.1538-7836.2008.03241.x https://archive-ouverte.unige.ch/unige:19813 |